Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

inTEST Updates Full Year 2024 Guidance Due To Alfamation Acquisition; Boosts 2024 Revenue Outlook From $125M-$130M To $145M-$155M; Est $125.795M

Author: Benzinga Newsdesk | March 12, 2024 04:23pm

The acquisition is expected to be dilutive to earnings per diluted share in 2024, but accretive to non-GAAP adjusted EPS due to the anticipated impacts associated with the amortization of intangible assets. Given the timing of the acquisition, the impact to first quarter 2024 results from operations are expected to be nominal.

Posted In: INTT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist